New technologies for cervical cancer screening

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 26, Issue 2, 2012, Pages 233-242

  Brown, Alaina J ^a   Trimble, Cornelia L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

cancer; HPV; screening

Indexed keywords

BIOLOGICAL MARKER; VIRUS DNA;

ARTICLE; CANCER RISK; CANCER SCREENING; CELL PROLIFERATION; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; EPIGENETICS; FEMALE; GENOTYPE; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84858749896     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2011.11.001     Document Type: Article

References (39)

1. American Cancer Society. Global cancer facts and figures 2007; http://www.cancer.org/acs/groups/content/@nho/documents/document/ globalfactsandfigures2007rev2p.pdf [last accessed 01.11.11].
2. F.X. Bosch, A.N. Burchell, and M. Schiffman Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia Vaccine 26 Suppl. 10 2008 K1 16
3. National Cancer Institute. SEER data for 2000-2004; http://seer.cancer. gov/ [last accessed 01.11.11].
4. S.S. Wang, M.E. Sherman, and A. Hildesheim Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000 Cancer 100 2004 1035
5. American Cancer Society. Cancer facts and figures 2010; http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113. pdf [last accessed 01.11.11].
6. American Cancer Society. Cancer facts and figures for African-Americans 2009-2010; http://www.cancer.org/acs/groups/content/@nho/documents/document/ cffaa20092010pdf.pdf [last accessed 01.11.11].
7. American Cancer Society. Cancer facts and figures for hispanic/latinos 2009-2011; http://www.cancer.org/acs/groups/content/@nho/documents/document/ ffhispanicslatinos20092011.pdf [last accessed 01.11.11].
8. M. Stanley HPV-immune response to infection and vaccination Infect Agent Cancer 5 2010 19
9. F.X. Bosch, and S. De Sanjose The epidemiology of human papillomavirus infection and cervical cancer Dis Markers 23 2007 213 227 (Pubitemid 47015785)
10. M. Schiffman, P.E. Castle, and J. Jeronimo Human papillomavirus and cervical cancer Lancet 370 2007 890 907 (Pubitemid 47371147)
11. M. Narisawa-Saito, and T. Kiyono Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins Cancer Sci 98 2007 1505 1511 (Pubitemid 47308443)
12. American Congress of Obstetricians and Gynecologists Cervical cytology screening 2009 ACOG Practice Bulletin number 109
13. J. Cuzick, C. Clavel, and K.U. Petry Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119 2006 1095 1101 (Pubitemid 44116919)
14. M.H. Mayrand, E. Duarte-Franco, and I. Rodrigues Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer N Engl J Med 357 2007 1579 1588 (Pubitemid 47598400)
15. Howlader N, Noone AM, Krapcho M, eds. SEER cancer statistics review, 1975-2008. National Cancer Institute, Bethesda, MD.
16. M. Follen, and R. Richards-Kortum Emerging technologies and cervical cancer J Natl Cancer Inst 92 2000 363 365 (Pubitemid 30154818)
17. M. Arbyn, R. Sankaranarayanan, and R. Muwonge Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India Int J Cancer 123 2008 153 160 (Pubitemid 351705203)
18. S.J. Goldie, J.J. Kim, and K. Kobus Cost-effectiveness of HPV 16, 18 vaccination in Brazil Vaccine 25 2007 6257 6270 (Pubitemid 47088030)
19. R. Sankaranarayanan, B.M. Nene, and S.S. Shastri HPV screening for cervical cancer in rural India N Engl J Med 360 2009 1385 1394
20. ASCCP. HPV genotyping clinical update 2009; http://www.asccp.org/ ConsensusGuidelines/HPVGenotypingClinicalUpdate/tabid/5963/Default.aspx [last accessed 01.11.11].
21. J. Cuzick, M. Arbyn, and R. Sankaranarayanan Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries Vaccine 26 Suppl. 10 2008 K29 K41
22. P.E. Gravitt, F. Coutlée, and T. Iftner New technologies in cervical cancer screening Vaccine 26 Suppl. 10 2008 K42 K52
23. Y.L. Qiao, J.W. Sellors, and P.S. Eder A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China Lancet Oncol 9 2008 929 936
24. N. Muñoz, F.X. Bosch, and S. de Sanjosé Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 518 527 (Pubitemid 36159887)
25. T.E. Schutzbank, and C.C. Ginocchio Assessment of clinical and analytical performance characteristics of an HPV genotyping test Diagn Cytopathol 2011 [Epub ahead of print]
26. M. Moberg, I. Gustavsson, and U. Gyllensten Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ Int J Cancer 112 2004 854 859 (Pubitemid 39435271)
27. P.E. Gravitt, M.B. Kovacic, and R. Herrero High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease Int J Cancer 121 2007 2787 2793 (Pubitemid 350136428)
28. M. Pett, and N. Coleman Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 212 2007 356 367 (Pubitemid 47099012)
29. A.P. Cullen, R. Reid, and M. Campion Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm J Virol 65 1991 606 612
30. L. Pirami, V. Giache, and A. Becciolini Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix J Clin Pathol 50 1997 600 604 (Pubitemid 27359520)
31. I. Tsoumpou, M. Arbyn, and M. Kyrgiou p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis Cancer Treat Rev 35 2009 210 220
32. P.E. Castle, J. Dockter, and C. Giachetti A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer Clin Cancer Res 13 2007 2599 2605 (Pubitemid 46788025)
33. T. Molden, J.F. Nygrd, and I. Kraus Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL Pap smear Int J Cancer 114 2005 973 976
34. J. Schweizer, P.S. Lu, and C.W. Mahoney Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer J Clin Microbiol 48 2010 4646 4648
35. N. Wentzensen, M.E. Sherman, and M. Schiffman Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science Gynecol Oncol 112 2009 293 299
36. Q. Feng, S.E. Hawes, and J.E. Stern Promoter hypermethylation of tumor suppressor genes in urine from patients with cervical neoplasia Cancer Epidemiol Biomarkers Prev 16 2007 1178 1184 (Pubitemid 46984956)
37. S. Andersson, P. Sowjanya, and D. Wangsa Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears Am J Pathol 175 2009 1831 1847
38. K. Heselmeyer-Haddad, K. Sommerfeld, and N.M. White Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer Am J Pathol 166 2005 1229 1238 (Pubitemid 40524445)
39. N. Murphy, M. Ring, and C.C. Heffron p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer J Clin Pathol 58 2005 525 534 (Pubitemid 40646875)